304 related articles for article (PubMed ID: 20350427)
1. [Clinical and pathological features of Alport syndrome in children].
Zhu CH; Huang SM; Wu HM; Bao HY; Chen Y; Han Y; Zhao F; Zhang AH; Zhang WZ
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):188-91. PubMed ID: 20350427
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological study of 47 cases with Alport syndrome].
He X; Liu GL; Xia ZK; Ren XG; Gao YF; Fan ZM; Fu YF; Fu J; Gao CL; Mao S; Chen R
Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):914-8. PubMed ID: 19134254
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome.
Wei G; Zhihong L; Huiping C; Caihong Z; Zhaohong C; Leishi L
Nephrol Dial Transplant; 2006 Nov; 21(11):3146-54. PubMed ID: 16940319
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
7. [Pathological features and clinical manifestations in 313 children with nephropathy under 6].
Dang XQ; Cao Y; Yi ZW; Xu ZC; He XJ; Huang DL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):227-32. PubMed ID: 18382057
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
[TBL] [Abstract][Full Text] [Related]
9. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
10. [Significance of family studies and kidney biopsies in children with renal hematuria].
Pistor K; Bachmann H; Rumpelt HJ; Olbing H
Monatsschr Kinderheilkd; 1985 May; 133(5):269-73. PubMed ID: 4010678
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and genetic features of the Alport 'syndromes'].
Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
[TBL] [Abstract][Full Text] [Related]
12. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
13. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
15. Hereditary glomerulonephritis of non-Alport type.
Doherty CC; Middleton DT; Hill CM
Proc Eur Dial Transplant Assoc; 1983; 19():575-81. PubMed ID: 6878256
[TBL] [Abstract][Full Text] [Related]
16. [Collagen IV (alpha3-alpha4) nephropathy].
Torra R; Tazón B; Ars E; Ballarín J
Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
18. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
19. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
[TBL] [Abstract][Full Text] [Related]
20. [A case of Alport syndrome diagnosed by immunofluorescence using a newly defined monoclonal antibody].
Ohtomo Y; Yabuta K; Shirato I; Tomino Y; Shirai T
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):105-10. PubMed ID: 2190029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
